Published: 2022-07-27

A study of prevalence of peripheral neuropathy in patients with impaired glucose tolerance

Sumit Gupta, Harsha Sundaramurthy, Nemichandra S. C., Shasthara Paneyala


Background: It is estimated that about half of the diabetics develop diabetic peripheral neuropathy (DPN). Prediabetes is the precursor of type 2 diabetes and it is projected that by 2045 nearly 8.6% of the global adult population may be affected by prediabetes. Pre diabetics also shares the vascular complications of diabetes. Evaluation of impaired glucose tolerance (IGT) and its association with neuropathy is hence very essential. According to International Diabetes Federation, number of global impaired glucose regulation (IGR) patients will reach 471 million by 2035. It is imperative that management strategies aimed at timely diagnosis and prevention of these complications be framed.

Methods: 30 patients with IGT were recruited from outpatient/inpatient department of JSS hospital who met the following WHO diagnostic criteria (HbA1C of 5.7-6.4%, fasting blood sugar of 100-125 mg/dl, oral glucose tolerance test (OGTT) 2-hour blood sugar of 140-199 mg/dl) were included in the study. All the patients underwent nerve conduction studies as per the established clinical practice and results were compared with the standard values of our laboratory.

Results: 13 patients (43.33%) had neuropathy based on nerve conduction studies (NCS). Sensory neuropathy (53.85%) was most common followed by motor and mixed types with 3 patients each (23.08%).

Conclusions: Prevalence of neuropathy was high in prediabetics. Small fibre involvement as manifested by sensory component was predominant in our study. Family history of diabetes was an important risk factor associated with higher neuropathy prevalence.



Pre-diabetes, Peripheral neuropathy, IGT, IGR

Full Text:



Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants. The Lancet. 2016;387(10027):1513-30.

Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Med. 1998;15(6):508-14.

Johnsen B, Fuglsang-Frederiksen A. Electrodiagnosis of polyneuropathy. Clin Neurophysiol. 2000;30(6):339-51.

Kurisu S, Sasaki H, Kishimoto S, Hirayasu K, Ogawa K, Matsuno S, et al. Clinical polyneuropathy does not increase with prediabetes or metabolic syndrome in the Japanese general population. J Diabetes Investig. 2019;10(6):1565-75.

Lu B, Hu J, Wen J, Zhang Z, Zhou L, Li Y, et al. Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes–ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS One. 2013;8(4):e61053.

Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. The Lancet. 1999;354(9179):622-5.

Liu N, Zhang J, Zhang Z, Zhu J, Tian L, Li Q, et al. Impact of impaired glucose regulation on the functions of large and small fibers of peripheral nerves. Turkish J Med Sci. 2018;48(6):1207-13.

Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes. 2015;6:296-303.

Singleton JR, Smith GA, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001;24:1448-53.

Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research India Diabetes (ICMR-INDIAB) study. Diabetologia. 2011;54:3022-7.

Kannan MA, Sarva S, Kandadai RM, Paturi VR, Jabeen SA, Borgohain R. Prevalence of neuropathy in patients with impaired glucose tolerance using various electrophysiological tests. Neurology India. 2014;62(6):656.

Fateh HR, Madani SP, Heshmat R, Larijani B. Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy. J Diabetes Metab Disord. 2016;15(1):1-5.

Kirthi V, Perumbalath A, Brown E, Nevitt S, Petropoulos IN, Burgess J, et al. Prevalence of peripheral neuropathy in pre-diabetes: a systematic review. BMJ Open Diabetes Res Care. 2021;9(1):e002040.

Talib SH, Punde G, Dase RK. Nerve Conduction Abnormalities in Pre-Diabetics and Asymptomatic Diabetics. J Assoc Physicians India. 2018;66(4):29-32.

Brett SA. Peripheral Neuropathy in Patients with Prediabetes. Diabetes Care. 2015.

Sahin M, Karatas M, Sahin M, Ertugrul D, Kulaksizoðlu M, Dogruk A, et al. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels. Minerva Endocrinol. 2008;33:289-96.

Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131:633-43.

Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008;31:464-9.